Wellington Management Group LLP Cytokinetics Inc Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
A detailed history of Wellington Management Group LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,408,561 shares of CYTK stock, worth $492 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,408,561
Previous 7,827,679
5.35%
Holding current value
$492 Million
Previous $259 Million
57.44%
% of portfolio
0.07%
Previous 0.05%
Shares
22 transactions
Others Institutions Holding CYTK
# of Institutions
423Shares Held
129MCall Options Held
5.74MPut Options Held
1.37M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct6MShares$399 Million0.17% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...